Repository logo
 
Publication

Calcineurin inhibitor-free immunosuppression in renal transplantation

dc.contributor.authorParada, B
dc.contributor.authorMota, A
dc.contributor.authorNunes, P
dc.contributor.authorMacário, F
dc.contributor.authorPratas, J
dc.contributor.authorBastos, C
dc.contributor.authorFigueiredo, A
dc.date.accessioned2011-09-07T11:25:19Z
dc.date.available2011-09-07T11:25:19Z
dc.date.issued2005
dc.description.abstractPURPOSE: To describe our initial results using a calcineurin inhibitor-free immunosuppression protocol in renal transplants. PATIENTS AND METHODS: Between October 2001 and June 2003, 56 recipients of a renal allografts were started on an immunosuppression protocol without calcineurin inhibitors, consisting of basiliximab, sirolimus, mycophenolate mofetil, and steroids. We analyzed patient and graft survival, acute rejection episodes, and renal function. RESULTS: The mean follow-up was 19.6 months. Actuarial patient survival at 1 and 2 years was 98.1% and 95.3%, respectively. Actuarial graft survival at 1 and 2 years was 92.9% and 87.6%, respectively. Acute rejection occurred in 27.8% of the patients, usually Banff 1 (73.3%). There was stable renal function with mean serum creatinine of 1.3, 1.4, 1.3, and 1.3 mg/dL at 1, 6, 12, and 24 months after transplant. CONCLUSIONS: The use of immunosuppression free of calcineurin inhibitors is effective and safe. Further follow-up is needed to evaluate the impact on long-term results.por
dc.identifier.citationTransplant Proc. 2005 Jul-Aug;37(6):2759-61.por
dc.identifier.urihttp://hdl.handle.net/10400.4/1055
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.subjectInsuficiência Renal Crónicapor
dc.subjectTransplantação de Rimpor
dc.subjectCalcineurinapor
dc.subjectImunossupressorespor
dc.titleCalcineurin inhibitor-free immunosuppression in renal transplantationpor
dc.typejournal article
dspace.entity.typePublication
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files